Literature DB >> 15523501

Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness.

Clara D M van Karnebeek1, Maaike C E Jansweijer, Arnold G E Leenders, Martin Offringa, Raoul C M Hennekam.   

Abstract

There are no guidelines available for diagnostic studies in patients with mental retardation (MR) established in an evidence-based manner. Here we report such study, based on information from original studies on the results with respect to detected significant anomalies (yield) of six major diagnostic investigations, and evaluate whether the yield differs depending on setting, MR severity, and gender. Results for cytogenetic studies showed the mean yield of chromosome aberrations in classical cytogenetics to be 9.5% (variation: 5.4% in school populations to 13.3% in institute populations; 4.1% in borderline-mild MR to 13.3% in moderate-profound MR; more frequent structural anomalies in females). The median yield of subtelomeric studies was 4.4% (also showing female predominance). For fragile X screening, yields were 5.4% (cytogenetic studies) and 2.0% (molecular studies) (higher yield in moderate-profound MR; checklist use useful). In metabolic investigations, the mean yield of all studies was 1.0% (results depending on neonatal screening programmes; in individual populations higher yield for specific metabolic disorders). Studies on neurological examination all showed a high yield (mean 42.9%; irrespective of setting, degree of MR, and gender). The yield of neuroimaging studies for abnormalities was 30.0% (higher yield if performed on an indicated basis) and the yield for finding a diagnosis based on neuroradiological studies only was 1.3% (no data available on value of negative findings). A very high yield was found for dysmorphologic examination (variation 39-81%). The data from this review allow conclusions for most types of diagnostic investigations in MR patients. Recommendations for further studies are provided.

Entities:  

Mesh:

Year:  2005        PMID: 15523501     DOI: 10.1038/sj.ejhg.5201279

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  49 in total

1.  Subtelomeric rearrangements in Polish subjects with intellectual disability and dysmorphic features.

Authors:  J Bogdanowicz; B Pawłowska; A Ilnicka; S Gawlik-Zawiślak; A Jóźwiak; B Sobiczewska; E Zdzienicka; L Korniszewski; J Zaremba
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

Review 2.  Novel approaches to studying the genetic basis of cerebellar development.

Authors:  Samin A Sajan; Kathryn E Waimey; Kathleen J Millen
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

Review 3.  Genomic copy number variation in disorders of cognitive development.

Authors:  Eric M Morrow
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11       Impact factor: 8.829

Review 4.  Medical comorbidities in autism: challenges to diagnosis and treatment.

Authors:  Margaret L Bauman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 5.  Fragile X: leading the way for targeted treatments in autism.

Authors:  Lulu W Wang; Elizabeth Berry-Kravis; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 6.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

Review 7.  Diagnostic genome profiling: unbiased whole genome or targeted analysis?

Authors:  Joris A Veltman; Bert B A de Vries
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

Review 8.  Chromosome analysis: what and when to request.

Authors:  F H Sharkey; E Maher; D R FitzPatrick
Journal:  Arch Dis Child       Date:  2005-12       Impact factor: 3.791

9.  Chromosomal abnormalities associated with mental retardation in female subjects.

Authors:  Samikshan Dutta; Jyothi Shaw; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Indian J Hum Genet       Date:  2009-01

10.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.